Glenmark Pharmaceuticals sees potential of NONS to prevent Covid-19
Glenmark Pharmaceuticals plans to test its upcoming nitric oxide nasal spray (NONS) that it has licensed from a Canadian
Read moreGlenmark Pharmaceuticals plans to test its upcoming nitric oxide nasal spray (NONS) that it has licensed from a Canadian
Read moreGlenmark Pharmaceuticals on Friday said its consolidated profit after tax (PAT) increased by 21 per cent to Rs
Read moreFavipiravir, used to treat Covid-19 patients with mild to moderate symptoms, is witnessing a pricing war with
Read moreGlenmark, which markets favipiravir under brand Fabiflu for treatment of mild-to-moderate Covid-19 patients, has come under the
Read more